SCHEMBL7912909

SCHEMBL7912909

CC(=O)NNc1ccc2ccccc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.60
ALOX5 P09917 1/20 0.60
TSHR P16473 1/20 0.60
LMNA P02545 6/20 0.59
SMN1; SMN2 Q16637 6/20 0.59
GAA P10253 5/20 0.59
KDM4E B2RXH2 4/20 0.59
HTT P42858 1/20 0.59
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
ALDH1A1 P00352 3/20 0.56
CYP1A2 P05177 2/20 0.56
CYP2C19 P33261 1/20 0.56
HIF1A Q16665 1/20 0.56
GFER P55789 1/20 0.52
RAB9A P51151 8/20 0.51
NPC1 O15118 7/20 0.51
MAPT P10636 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.50
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL526574 0.83 KDM4E (0.71) CYP3A4LMNASMN1; SMN2GAAKDM4E
SCHEMBL3294926 0.81 KDM4E (0.59) CYP3A4LMNASMN1; SMN2GAAKDM4E
SCHEMBL1176635 0.81 MEN1 (0.69) LMNASMN1; SMN2GAAKDM4EHTT
SCHEMBL6638890 0.81 LMNA (0.55) LMNASMN1; SMN2GAAKDM4EHTT
Anthracene SCHEMBL29076817 0.79 MEN1 (0.67) LMNASMN1; SMN2GAAKDM4EHTT
SCHEMBL6636514 0.79 PTGS2 (0.65) LMNASMN1; SMN2GAAKDM4EHTT
SCHEMBL6632475 0.79 DEGS1 (0.64) LMNASMN1; SMN2GAAKDM4EHTT
SCHEMBL19277763 0.78 GAA (0.60) LMNASMN1; SMN2GAAKDM4EMEN1
SCHEMBL3082430 0.77 KDM4E (0.55) CYP3A4LMNASMN1; SMN2GAAKDM4E
SCHEMBL1648784 0.77 ALDH1A1 (0.62) CYP3A4LMNASMN1; SMN2GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492425-B2 5-methyl-1-(naphthalen-2-yl)-1H-pyrazoles useful as sigma receptor inhibitors LABORATORIES DEL DR. ESTEVE, S.A. (ES) 2013-07-23 US disclosed
US-20110118253-A1 5-METHYL-1-(NAPHTHALEN-2-YL)-1H-PYRAZOLES USEFUL AS SIGMA RECEPTOR INHIBITORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2011-05-19 US disclosed
EP-0872903-B1 Method for making hydrogen storage alloy powder and electrode comprising the alloy powder SHINETSU CHEMICAL CO (JP) 2001-10-04 EP disclosed
US-6277519-B1 QUENCHING AN ALLOY MELT; COMMINUTION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2001-08-21 US disclosed
US-6096144-A TREATING WITH ACIDIC OR ALKALINE SOLUTION OF CONJUGATED UNSATURATED COMPOUND WITH AT LEAST 5 BONDS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2000-08-01 US disclosed
US-5858571-A TREATING A PULVERIZED HYDROGEN ABSORBING ALLOY WITH A SOLUTION COMPRISING A CONJUGATED UNSATURATED COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 1999-01-12 US disclosed
EP-0872903-A1 Method for making hydrogen storage alloy powder and electrode comprising the alloy powder Shin-Etsu Chemical Co., Ltd. (JP) 1998-10-21 EP disclosed
EP-0172427-B1 PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER Shin-Etsu Chemical Co., Ltd. (JP) 1989-07-05 EP disclosed
US-4758639-A Process for production of vinyl polymer SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-19 US disclosed
US-4757124-A Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-12 US disclosed
EP-0172427-A2 Process for production of vinyl chloride polymer Shin-Etsu Chemical Co., Ltd. (JP) 1986-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118253-A1 5-METHYL-1-(NAPHTHALEN-2-YL)-1H-PYRAZOLES USEFUL AS SIGMA RECEPTOR INHIBITORS SIGMAR1, OPRM1, OPRK1 CYP3A4 157/4885ALOX5 673/4885TSHR 560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.